Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × talazoparib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 mCRPC 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 19 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Fluorouracil 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Radiosurgery 3 Immunoglobulin G 3 Fulvestrant 3 Drug Therapy 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡